A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider

PHASE4CompletedINTERVENTIONAL
Enrollment

498

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Smoking Cessation
Interventions
DRUG

Varenicline

Varenicline 1mg twice daily

DRUG

Placebo

Matched placebo twice daily

Trial Locations (37)

2035

Australian Clinical Research Network, Maroubra

2650

Universitair Ziekenhuis Antwerpen, Afdeling Pneumologie, Edegem

3000

Universitaire Ziekenhuizen Leuven/Pneumologie, Leuven

3145

Emeritus Research, Malvern

4000

Centre Hospitalier Universitaire de Liege, Liège

4029

Royal Brisbane and Women's Hospital, Herston

4075

AusTrials Australia, Sherwood

5530

Cliniques Universitaires U.C.L. de Mont-Godinne/Laboratoire, Yvoir

10787

Klinische Forschung Berlin, Berlin

14033

CHU Côte de Nacre, Unité de Coordination de Tabacologie, Caen

20253

Klinische Forschung Hamburg GmbH, Hamburg

20742

The University of Maryland, College Park

29609

CHU de la Cavale Blanche, Brest

32720

Avail Clinical Research, LLC, DeLand

34295

Hopital Arnaud de Villeneuve, Montpellier

37075

Universitaetsklinikum Goettingen Zentrum Innere Medizin Abteilung Kardiologie und Pneumologie, Göttingen

37203

Clinical Research Associates, Inc., Nashville

40509

Central Kentucky Research Associates, Inc., Lexington

41460

FOCUS Clinical Drug Development GmbH, Neuss

64114

The Center for Pharmaceutical Research, PC, Kansas City

80336

Ludwig Maximilians-Universitaet Muenchen, München

90095

University of California Los Angeles David Geffen School of Medicine, Los Angeles

90095-6984

Ronald Reagan University of California Los Angeles Medical Center, Los Angeles

97239-3098

Oregon Health and Science University, Portland

V5G 1T4

Office of Dr. Ronald Collette, Burnaby

A1A 3R5

White Hills Medical Clinic, St. John's

M3H 5S4

Canadian Phase Onward Inc., Toronto

G1V 4M6

Clinique des maladies Lipidiques de Quebec, Québec

625 00

Fakultni nemocnice Brno, Brno

460 01

Krajska nemocnice Liberec a.s., Plicni oddeleni, Liberec

728 80

Mestska nemocnice Ostrava, Plicni oddeleni, Ostrava

120 00

Vseobecna fakultni nemocnice v Praze, Prague

RG2 0TG

Synexus Thames Valley Clinical Research Centre, Reading

PR7 7NA

Synexus Lancashire Clinical Research Centre, Chorley

G20 0SP

Synexus Scotland Clinical Research Centre, Glasgow

L22 0LG

Synexus, Merseyside Clinical Research Centre, Liverpool

EC1M 6BQ

William Harvey Research Institute,, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01244061 - A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider | Biotech Hunter | Biotech Hunter